Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.21.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2021
Segment Information  
Schedule of Segment Information

The Company operates in two reportable segments, Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The accounting policies of the Company’s segments are the same as those described in Note 2. The following tables summarize, for the periods indicated, operating results from continued operations by reportable segment:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Pharmaceutical

​

    

​

​

​

​

​

​

and

​

​

​

($ in thousands)

​

Dermatology

​

Biotechnology

​

​

​

​

​

Products

​

Product

​

​

​

Three Months Ended March 31, 2021

    

Sales

    

Development

    

Consolidated

Net revenue

​

$

10,719

​

$

868

​

$

11,587

Direct cost of goods

​

 

(3,908)

​

 

—

​

 

(3,908)

Sales and marketing costs

​

 

(5,070)

​

 

—

​

 

(5,070)

Research and development

​

 

—

​

 

(20,154)

​

 

(20,154)

General and administrative

​

​

(1,156)

​

​

(11,316)

​

​

(12,472)

Other expense

​

 

(221)

​

 

4,172

​

 

3,951

Segment income (loss)

​

$

364

​

​

(26,430)

​

$

(26,066)

Segment assets

​

​

​

​

​

​

​

​

​

Intangible assets, net

​

​

14,442

​

​

—

​

​

14,442

Tangible assets

​

​

42,200

​

​

334,401

​

​

376,601

Total segment assets

​

$

56,642

​

$

334,401

​

$

391,043

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Pharmaceutical

​

​

​

​

​

​

​

​

and

​

​

​

​

​

Dermatology

​

Biotechnology

​

​

​

($ in thousands)

​

Products

​

Product

​

​

​

Three Months Ended March 31, 2020

    

Sales

    

Development

    

Consolidated

Net revenue

​

$

11,946

​

$

972

​

$

12,918

Direct cost of goods

​

 

(3,810)

​

 

—

​

​

(3,810)

Sales and marketing costs

​

 

(4,679)

​

 

—

​

​

(4,679)

Research and development

​

 

—

​

 

(15,117)

​

​

(15,117)

General and administrative

​

 

(953)

​

 

(9,887)

​

​

(10,840)

Other expense

​

​

(207)

​

​

(2,333)

​

​

(2,540)

Segment income (loss)

​

$

2,297

​

$

(26,365)

​

$

(24,068)

Segment assets

​

​

​

​

​

​

​

​

​

Intangible assets, net

​

​

7,022

​

​

—

​

​

7,022

Tangible assets

​

​

23,550

​

​

198,187

​

​

221,737

Total segment assets

​

$

30,572

​

$

198,187

​

$

228,759